Loading…
Loading grant details…
| Funder | NATIONAL HEART, LUNG, AND BLOOD INSTITUTE |
|---|---|
| Recipient Organization | Johns Hopkins University |
| Country | United States |
| Start Date | Feb 10, 2021 |
| End Date | Jan 31, 2026 |
| Duration | 1,816 days |
| Number of Grantees | 1 |
| Roles | Principal Investigator |
| Data Source | NIH (US) |
| Grant ID | 10768767 |
Clonal hematopoiesis of indeterminate potential (CHIP) defined as acquisition of somatic mutations in hematopoietic cells is a common age-related condition. The prevalence of CHIP exceeds 12% over all age groups and nearly 50% for subjects older than 85-years. Since somatic mutations frequently affect putative
cancer drivers the malignant transformation to myelodysplasia or leukemia is an obvious concern. Even though CHIP is relatively common, the risk of progression to clinically apparent disease is low (
Johns Hopkins University
Complete our application form to express your interest and we'll guide you through the process.
Apply for This Grant